Explore our resources articles publications news events

Select what you are interested in:

Our articles

Building the Future of C. difficile Research with a Human Infection Model

Clostridioides difficile (C. difficile) remains a major cause of healthcare-associated diarrhoea, with rising antibiotic resistance and frequent relapses making treatment…

Female-Only Schistosomiasis Infection Model Reveals Surprising Resistance

In this study schistosomiasis research is boosted by developing the first controlled human infection model using female-only Schistosoma mansoni parasites….

Genetically Attenuated Parasites Ushers In a New Era in Malaria Vaccination

Despite decades of effort, malaria remains a global health challenge, with current vaccines offering only modest and short-lived protection. This…

New Hope for Vaccine Development for Hookworm Infection

Hookworm remains a persistent health threat in many parts of the world, with reinfection common despite mass drug treatments. This…

Latest publications

July 7, 2025

Hensen, A.D.O., et al. How to develop a controlled human infection model for Clostridioides difficile. CMI. 2025;31(3): 373-379.

July 5, 2025

Koopman JPR, Houlder EL, Janse JJ, et al. Safety and infectivity of female cercariae in unexposed, healthy participants: a controlled human Schistosoma mansoni infection study. Lancet eBioMedicine. 2023

July 4, 2025

Lamers OAC, Franke-Fayard BMD, Koopman JPR, et al. Safety and protection by a late-liver-stage attenuated malaria parasite. New England Journal of Medicine. 2024

July 3, 2025

Hoogerwerf, M.A., et al., Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial. Lancet Microbe, 2023. 4(12): p. e1024-e1034.

Events you can meet us at

17-20 February

ReSViNET Conference

20-21 October

World Vaccine Congress Europe 2026

News from INFECTA

Our new website is live

December 2, 2025

With the launch of our extended website we gain the ability to showcase more information on our CHIMs repository, our services and our values….

Discussion with our COO on BNR Nieuwsradio

November 26, 2025

Today our COO Ingrid de Visser-Kamerling was live on the BNR Nieuwsradio with Koenraad Wiedhaup to talk about the recent developments in infectious disease…

INFECTA and AHAM Vastgoed to develop innovative clinical research facility at Leiden Bio Science Park

November 25, 2025

Leiden, 26 November 2025 – INFECTA, a Dutch clinical research organization specializing in infectious diseases, has signed a collaboration agreement with AHAM Vastgoed for…

One Year Anniversary of INFECTA

November 4, 2025

Celebrating our 1 year anniversary at the first FAST – Centre for Future Affordable Sustainable Therapy Development event today with cake!

…

Interview with Meta Roestenberg on BNR Zakendoen

October 21, 2025

Today, our CEO Meta Roestenberg was live on BNR Zakendoen! In the interview, she outlined INFECTA’s approach: to accelerate the development of vaccines and…

Presentation at The World Vaccine Congress

October 15, 2025

This afternoon, our COO Ingrid de Visser-Kamerling gave a presentation at The World Vaccine Congress about the advantages and impact of using Controlled Human…